Nemerovski C;Hutchinson DJ.Treatment of hypervolemic or euvolemic hyponatremia associated with heart failure, cirrhosis, or the syndrome of inappropriate antidiuretic hormone with tolvaptan: a clinical review.,2010Nemerovski C,Hutchinson DJ. Treatment of hypervolemic or euv- olemic hyponatremia ...
Palmer BF, rock AD, Woodward EJ, Dose comparison of conivaptan (vaprisol(R)) in patients with euvolemic or hypervolemic hyponatremia- efficacy, safety, and pharmacokinetics[J]. Drug Des Devel Ther, 2016, 10(2):339-351.Palmer BF, Rock AD, Woodward EJ (2016) Dose comparison...
This article presents the findings of an observational study conducted in India on the effectiveness of tolvaptan in patients with euvolemic and hypervolemic hyponatremia. The study involved 82 patients and found that tolvaptan was highly effective in increasin...
Assessment of the efficacy and safety of intravenous conivaptan in euvolemic and hypervolemic hyponatremia. Am J Nephrol 2007; 27(5): 447–457.Zeltser D, Rosansky S, van Rensburg H, Verbalis JG, Smith N. Conivaptan Study Group. Assessment of the efficacy and safety of intravenous...
Methods Conivaptan was evaluated in a randomized controlled trial (RCT) of 84 patients and in an open-label study (OLS) of 251 patients, all with euvolemic or hypervolemic hyponatremia. After infusion of a 20-mg loading dose, conivaptan was given in a continuous 4-day infusion of 40 ...
Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervolemic hyponatremia. Am J Health Syst Pharm. 2011;68(9):818-27.Koren MJ,Hamad A,Klasen S,Abeyratne A,McNutt BE,Kalra S. Efficacy and safety of 30-minute infusions of conivaptan in euvolemic and hypervol...
Hang, X.; Zhao, M.; Du, W.; Zu, D.; Sun, Y.; Xiang, R.; Yang, J. Efficacy and Safety of Vasopressin Receptor Antagonists for Euvolemic or Hypervolemic Hyponatremia: A Meta-Analysis. Medicine 2016, 95, e3310. [CrossRef]